Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.
Delivering cancer drugs directly to tumors is difficult. Scientists are working on new approaches to overcome the natural limitations of drugs, including loading them into nanoparticles.
“The drug is packaged into a lipid ball significantly smaller than the width of a hair to make it soluble in the blood stream and prevent negative side effects. The drug-containing nanoparticle ball then travels in the bloodstream to the tumor, where it accumulates and the drug is released in the tumor to kill the cancer cells,” said Gavin Robertson, professor of pharmacology, pathology, dermatology, and surgery and director of the Penn State Hershey Melanoma Center.
In previous research, Robertson discovered the cancer-fighting characteristics of leelamine, a substance derived from pine bark. But leelamine cannot be given by mouth because of poor uptake in the gastrointestinal tract or be injected intravenously because it causes damage to red blood cells.
To address this issue, Robertson and his team developed a new nanoliposome that loads leelamine, called Nanolipolee-007. Nanolipolee-007 can be injected intravenously without causing damage to red blood cells. It then accumulates in tumors because of its small size where it releases the drug to kill the cancer cells.
Leelamine is the first of a new unique class of drugs that inhibits cholesterol movement around a cancer cell to shut down signals needed for cancer cell survival. As a result, protein pathways like the PI3K, MAPK and STAT3 that are highly active and help cancer cells multiply and spread, are turned off and the cancer cells die. Since normal cells are not addicted to the high levels of activity of these pathways that occur in cancer cells, the drug has a minor effect on them.
“This nanoparticle moves leelamine one step closer to the clinic,” Robertson said. “We now have a drug that has the potential to be given to humans that could not be done before.”
The researchers showed the results of Nanolipolee-007 on cells growing in culture dishes and in tumors growing in mice following intravenous injection. Leelamine inhibited tumor development in mice with no detectable side effects.
The Latest on: Drug-containing nanoparticle
via Google News
The Latest on: Drug-containing nanoparticle
- Stimulus-responsive Macromolecules and Nanoparticles for Cancer Drug Deliveryon April 2, 2020 at 5:00 pm
Nanomedicine. 2010;5(5):793-806. Stimulus-responsive carriers provide additional opportunities to improve the tumor accumulation of systemically delivered drug carriers by triggering changes in ...
- Bacteria as Living Microrobots to Fight Canceron March 31, 2020 at 10:29 pm
Sylvain Martel of Polytechnique Montréal and colleagues attached drug-containing nanoliposomes onto a magnetotatic bacterial strain called MC-1 that was injected in close proximity to tumors in mice.
- African American Scientist Breaks Ground in Cancer Researchon March 31, 2020 at 5:00 pm
(Photo: YouTube) She spent more than seven years developing a way to target cancer cells – not the healthy cells around them. Dr. Green’s technology uses an FDA-approved drug containing nanoparticles ...
- Targeted Drug Delivery of Microbubble to Arrest Abdominal Aortic Aneurysm Development: A Simulation Study Towards Optimized Microbubble Designon March 25, 2020 at 3:11 am
The present study is aimed to investigate the surface adhesion of different types of drug-containing MBs to the inner wall of AAA through ligand-receptor binding, using fluid-structure interaction ...
- NanoART, NeuroAIDS and CNS Drug Deliveryon March 10, 2020 at 5:00 pm
 This pH-dependent release of drug-containing NPs could be very useful ... glycol-disteroyl phosphatidylethanolamine; NP: Nanoparticle; PBCA: Polybutylcyanoacrylate. The CNS is separated ...
- Alcohol News and Researchon March 4, 2020 at 4:00 pm
Cannabis is a plant-derived drug containing the psychoactive ingredient delta-9-tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). These cannabinoids are broken down by the liver ...
- A competent bidrug loaded water soluble chitosan derivative for the effective inhibition of breast canceron March 4, 2020 at 2:46 am
Tween 80 (0.5% (v/v)) was added to the above mixture. The dual drug containing CMCS solution was flush mixed with 1 mg/mL TPP solutions at a ratio of (2: 1) (v/v) (CMCS: TPP). The suspension was ...
- 2011 Publicationson January 11, 2019 at 6:42 pm
Emileh, A.; Abrams, C.F. A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120 ...
- High Throughput Microfluidic Assembly of Uniform Polymersome Nanocompositeson February 20, 2017 at 2:36 am
Bulk methods of polymersome assembly; however, are generally inefficient at encapsulating expensive therapeutics and yield nanoparticles of a variety ... a shear force capable of pinging off the ...
- Alpha Particles Target Canceron May 30, 2014 at 8:48 am
In May 2013, the Food and Drug Administration (FDA) approved the first cancer treatment drug containing an alpha-emitting isotope ... embedding alpha emitters inside a layered, gold-coated ...
via Bing News